Details

Autor(en) / Beteiligte

• Frost, Shaun M
• Kanagasingam, Yogesan
• Sohrabi, Hamid R
• Taddei, Kevin
• Bateman, Randall
• Morris, John
• Benzinger, Tammie
• Goate, Alison
• Masters, Colin L
• Martins, Ralph N

Titel

Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers

Ist Teil von

• Current Alzheimer research, 2013-10, Vol.10 (8), p.790-796

Ort / Verlag

United Arab Emirates

Erscheinungsjahr

2013

Quelle

MEDLINE

Beschreibungen/Notizen

• Alzheimer's disease (AD) is usually only diagnosed many years after pathology begins. Earlier detection would allow emerging interventions to have a greater chance to preserve healthy brain function. A rare form of Alzheimer's disease, caused by autosomal-dominant mutations, affects carriers with 100% certainty and at a younger age specific to their mutation. Studying families with these mutations allows a unique investigation of the temporal sequence of biomarker changes in Alzheimer's disease. To determine whether the pupil flash response (PFR), previously reported to be altered in sporadic Alzheimer's disease, is different in pre-symptomatic mutation carriers. Researchers blinded to participant mutation status collected pupil response data from cognitively normal participants in the Dominantly Inherited Alzheimer's Network (DIAN) Study during 2010-2011. The pupil response was examined at the McCusker Alzheimer's Research Foundation in Perth, Western Australia. Participants were from a single family harboring an Amyloid-Beta Precursor Protein genetic mutation (APPGlu693Gln). Six carriers and six non-carriers were available for pupil testing (age 43.0±8.3 years old, 2 males and 10 females, 4 with hypertension). Pupil response parameter comparison between mutation carriers and non-carriers. 75% recovery time was longer in mutation carriers (p<0.0003, ROC AUC 1.000, Sensitivity 100%, Specificity 100%) and percentage recovery 3.5 seconds after stimulus was less in mutation carriers (p<0.006, ROC AUC 1.000, Sensitivity 100%, Specificity 100%). PFR changes occur pre-symptomatically in autosomal dominant AD mutation carriers, supporting further investigation of PFR for early detection of AD.